熱門資訊> 正文
Inspira Technology获得2250万美元的采购订单
2025-07-02 21:57
- Inspira Technologies (NASDAQ:IINN) on Wednesday announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system.
- The order was placed by a privately held company headquartered outside the United States, with a track record and active commercial ties to both government entities and institutional healthcare customers.
- Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025.
- IINN is +8.11% to $0.8798.
- Source: Press Release
More on Inspira Technologies Oxy B.H.N.
- Inspira stock soars on initiating global commercial rollout of ART100 system
- Inspira Technologies president Joe Hayon steps down
- Seeking Alpha’s Quant Rating on Inspira Technologies Oxy B.H.N.
- Historical earnings data for Inspira Technologies Oxy B.H.N.
- Financial information for Inspira Technologies Oxy B.H.N.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。